4//SEC Filing
Huang Michael F. 4
Accession 0001415889-25-009294
CIK 0001484565other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:18 PM ET
Size
25.8 KB
Accession
0001415889-25-009294
Insider Transaction Report
Form 4
Huang Michael F.
Sr. VP of Clinical Development
Transactions
- Sale
Common Stock
2025-03-27$66.79/sh−604$40,342→ 40,425 total - Sale
Common Stock
2025-03-27$68.79/sh−1,444$99,330→ 37,883 total - Sale
Common Stock
2025-03-27$65.97/sh−371$24,475→ 41,029 total - Sale
Common Stock
2025-03-27$70.73/sh−86$6,083→ 36,961 total - Sale
Common Stock
2025-03-27$71.74/sh−125$8,968→ 36,836 total - Sale
Common Stock
2025-03-27$70.03/sh−10,000$700,330→ 36,817 total - Sale
Common Stock
2025-03-27$67.70/sh−1,098$74,335→ 39,327 total - Sale
Common Stock
2025-03-27$69.84/sh−836$58,384→ 37,047 total - Sale
Common Stock
2025-03-27$72.64/sh−19$1,380→ 36,817 total - Exercise/Conversion
Common Stock
2025-03-27$21.93/sh+10,000$219,300→ 46,817 total - Exercise/Conversion
Employee stock option (right to buy)
2025-03-27−10,000→ 110,000 totalExercise: $21.93Exp: 2033-11-08→ Common Stock (10,000 underlying)
Footnotes (12)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F10]This transaction was executed in multiple trades at prices ranging from $72.31 to $72.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F11]This transaction was executed in multiple trades at prices ranging from $70.01 to $70.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F12]One-fourth of the shares subject to the option vest on November 1, 2024 and one-forty-eighth of the shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.
- [F2]This transaction was executed in multiple trades at prices ranging from $65.15 to $66.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- [F4]This transaction was executed in multiple trades at prices ranging from $66.24 to $67.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F5]This transaction was executed in multiple trades at prices ranging from $67.24 to $68.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F6]This transaction was executed in multiple trades at prices ranging from $68.24 to $69.225. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F7]This transaction was executed in multiple trades at prices ranging from $69.24 to $70.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F8]This transaction was executed in multiple trades at prices ranging from $70.24 to $71.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F9]This transaction was executed in multiple trades at prices ranging from $71.26 to $72.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
SOLENO THERAPEUTICS INC
CIK 0001484565
Entity typeother
Related Parties
1- filerCIK 0002019992
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 7:18 PM ET
- Size
- 25.8 KB